Latest news
Evolus (Nasdaq: EOLS) posts higher sales and manages sizable debt load - Stock TitanStock Titan · Wed, 05 Aug 2026 20:57:26 GMTEvolus (NASDAQ: EOLS) lifts 2026 guidance after Q2 revenue hits $84.1 million - Stock TitanStock Titan · Wed, 05 Aug 2026 20:18:02 GMTEvolus, Inc. (NASDAQ: EOLS) extends Estyme deal to $500M markets - Stock TitanStock Titan · Tue, 04 Aug 2026 12:46:29 GMTEvolus Expects 2028 Injectable Gel Launch Across 3 Markets - Stock TitanStock Titan · Tue, 04 Aug 2026 12:30:00 GMT